0001209191-16-141774.txt : 20160916
0001209191-16-141774.hdr.sgml : 20160916
20160916161559
ACCESSION NUMBER: 0001209191-16-141774
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160915
FILED AS OF DATE: 20160916
DATE AS OF CHANGE: 20160916
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAPLAN GILLA
CENTRAL INDEX KEY: 0001247024
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 161889588
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
FORMER NAME:
FORMER CONFORMED NAME: KAPLAN GILLA PHD
DATE OF NAME CHANGE: 20030625
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-09-15
0
0000816284
CELGENE CORP /DE/
CELG
0001247024
KAPLAN GILLA
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
1
0
0
0
Common Stock
2016-09-15
4
S
0
9710
106.44
D
72142
D
The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $106.26 to $106.66, inclusive. The reporting person undertakes to provide to Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
/s/ Mark J. Alles ________________________________________________
Mark J. Alles, Attorney-in-Fact
2016-09-16